not a problem, all drugs take millions to get to market.
MANF + AMBS are dedicated to complete the task..
that summary you provided is for ischemia, which is not the main focus for MANF... Parkinson's Disease is and the Positive efficacy Data recently presented allows AMBS to continue advancing MANF in both Investigational New Drug (“IND”)- enabling studies and human clinical studies
the Time frame is a lot sooner than you are thinking.. just be patient.
News 
Market Data 
Discover 
AI
